A second dose conferred an additional 67.9% effectiveness against any herpes zoster outcome. HealthDay News — Two doses of the recombinant zoster vaccine (RZV) are effective in older adults, including ...

In people living with HIV, the adjuvanted recombinant subunit herpes zoster vaccine shows a favorable short-term safety and ...

The recombinant zoster vaccine (Shingrix) is very effective against the viral rash, but research has found that it may also help prevent or treat dementia.

In adults aged 50 years or older, the 2-dose recombinant zoster vaccine is linked to reduced risk for HZO, acute myocardial infarction, and stroke. HealthDay News — Two doses of recombinant zoster ...

A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence. Subscribe to our ...

If you've ever had chickenpox, you are at risk of developing shingles in the future. While people might assume that shingles — a painful, blistering rash — only affects older adults, 1 in 3 ...

Herpes zoster (HZ) is common in older people, with a lifetime risk of 25%. The main risk factors are advanced age and immunosuppression. People with a rheumatic and musculoskeletal disease have an ...

To combat the rising cases of shingles, a particular scourge for older adults,  the health ministry will add its vaccination ...

Participants were Medicare beneficiaries aged 65 years or older with continuous Part D coverage, with no prior RZV vaccination. HealthDay News — Two doses of the recombinant zoster vaccine (RZV) are ...

"These data suggest that health benefits of RZV immunization may extend beyond the well-described prevention of herpes zoster and postherpetic neuralgia." HealthDay News — Two doses of recombinant ...

MONDAY, Oct. 20, 2025 (HealthDay News) -- Two doses of the recombinant zoster vaccine (RZV) are effective in older adults, including immunocompromised adults, according to a study published online Oct ...